CLINICAL_TRIALS
trial_result
· 2020-03-03
Clinical Trial Update: FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty [Phase 2]
Summary
Phase 2 trial update of FactOr XIa inhibition for prevention of venous thromboembolism in patients undergoing total knee arthroplasty.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Knee Arthroplasty, Total | Phase 2 | Status: COMPLETED